UPDATED Sep 24, 2025
Explore the U.S. (NYSE and NASDAQ) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.
| Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
QURE | US$47.50 | 247.7% | 885.5% | US$930.3m | US$51.76 | PS225.6x | E65.0% | n/a | ||
SMMT | US$20.50 | 7.0% | -9.5% | US$14.2b | US$32.55 | PB58.7x | E61.4% | n/a | ||
REGN | US$576.98 | 1.6% | -44.0% | US$58.9b | US$722.20 | PE13.4x | E8.5% | 0.6% | ||
WST | US$259.94 | 3.6% | -14.3% | US$18.0b | US$315.92 | PE38.3x | E11.6% | 0.3% | ||
ALNY | US$458.37 | 0.9% | 68.1% | US$59.6b | US$447.15 | PS24.4x | E54.1% | n/a | ||
SLNO | US$64.50 | 13.5% | 32.2% | US$3.0b | US$118.73 | PS105x | E61.3% | n/a | ||
CDTX | US$88.58 | 20.5% | 718.7% | US$1.9b | US$126.20 | PB4.5x | E31.9% | n/a | ||
BNTX | US$99.75 | 1.5% | -13.9% | US$23.6b | US$136.98 | PS7.1x | E19.1% | n/a | ||
JNJ | US$176.69 | 0.06% | 10.0% | US$425.3b | US$179.64 | PE18.8x | E2.1% | 2.9% | ||
IONS | US$63.94 | 2.2% | 56.0% | US$10.0b | US$72.14 | PS10.8x | E47.5% | n/a | ||
UTHR | US$438.75 | 1.1% | 22.0% | US$19.6b | US$476.09 | PE16x | E8.1% | n/a | ||
VKTX | US$26.63 | 6.6% | -57.8% | US$2.8b | US$92.29 | PB3.8x | E-9.5% | n/a | ||
EWTX | US$16.59 | 9.9% | -35.9% | US$1.6b | US$37.50 | PB3x | E18.6% | n/a | ||
EXAS | US$53.12 | 1.4% | -21.6% | US$9.9b | US$64.01 | PS3.4x | E85.4% | n/a | ||
RNA | US$43.21 | 2.2% | -6.0% | US$6.1b | US$68.32 | PS578.5x | E34.6% | n/a | ||
VTRS | US$9.71 | 1.1% | -13.8% | US$11.2b | US$11.43 | PB0.7x | E77.9% | 4.9% | ||
KYMR | US$52.50 | 3.2% | 1.1% | US$3.6b | US$62.95 | PS84x | E-10.9% | n/a | ||
ELAN | US$18.75 | 1.1% | 37.3% | US$9.2b | US$19.00 | PE21.5x | E-3.4% | n/a | ||
IMVT | US$15.46 | 3.8% | -45.6% | US$2.6b | US$40.21 | PB4.4x | E38.1% | n/a | ||
MLYS | US$38.87 | 3.2% | 227.5% | US$2.9b | US$43.75 | PB9.6x | E37.0% | n/a | ||
GPCR | US$25.63 | 6.7% | -38.9% | US$1.4b | US$73.21 | PB1.9x | E8.8% | n/a | ||
KOD | US$15.49 | 12.9% | 495.8% | US$723.1m | US$8.80 | PB11.6x | E14.6% | n/a | ||
CLDX | US$25.60 | 5.7% | -28.9% | US$1.6b | US$56.25 | PS293.6x | E27.0% | n/a | ||
MLTX | US$53.95 | 2.7% | 6.2% | US$3.3b | US$76.73 | PB9.7x | E41.8% | n/a |